Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjunctive minocycline for treatment-resistant unipolar major depressive disorder
2015-001456-29Phase 2Completed
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in major depressive disorder (MDD) comparing Minocycline adjunctive therapy with Placebo adjunctive therapy (2 arms). Primary endpoint: Change in MADRS score. Started Jul 2015; status: completed.
02
Drugs
minocycline
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on 2015-001456-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001456-29.